Literatur
Baujat B, Bourhis J, Blanchard P, MARCH Collaborative Group et al (2010) Hyperfractionated or accelerated radiotherapy for head and neck cancer. Cochrane Database Syst Rev CD002026. doi:10.1002/14651858.CD002026
Baumann M, Klages HT (2001) Vergleich verschiedener Fraktionierungsschemata bei der alleinigen kurativen Strahlentherapie lokal fortgeschrittener Kopf-Hals-Tumoren. Strahlenther Onkol 177:162–165
Beck-Bornholdt HP, Dubben HH (2000) Multiple Signifikanztests und ihre Bedeutung bei der Beurteilung von Resultaten. Strahlenther Onkol 176:344–349
Beitler JJ, Zhang Q, Fu KK et al (2014) Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 89:13–20
Bourhis J, Sire C, Graff P, Grégoire V et al (2012) Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol 13:145–153
Budach W, Hehr T, Budach V et al (2006) A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 6:28
Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098
Fu KK, Pajak TF, Trotti A et al (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7–16
Nguyen-Tan P, Zhang E, Wheeler RH et al (2013) A phase 3 trial to test accelerated versus standrad fractionation in combination with concurrent cisplatin for head and neck carcinomas (RTOG 0129): long-term report of efficacy and toxicity. Int J Radiat Oncol Biol Phys 87:S56–S57
Pignon JP, le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14
Einhaltung ethischer Richtlinien
Interessenkonflikt
H. T. Klages gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klages, H. „Bananenkurve“ im Überleben nach alleiniger Strahlentherapie fortgeschrittener Kopf-Hals-Karzinome. Strahlenther Onkol 190, 970–972 (2014). https://doi.org/10.1007/s00066-014-0729-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-014-0729-7